OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MTBI56

Multibase India Ltd

Commodity ChemicalsVerified

Multibase India Ltd maintains a strong liquidity position, with cash and equivalents amounting to INR 1,060,000,000, representing 73.4% of total assets. The company has no long-term debt and a debt-to-equity ratio of 0, indicating a conservative capital structure. The current ratio of 17.24 suggests a high ability to meet short-term obligations. Profitability metrics show a return on equity (ROE) of 2.93% and a return on assets (ROA) of 2.73%. These figures are below the industry median for Commodity Chemicals, which typically sees ROE and ROA in the 5-7% range. The company's net income of INR 39,450,000 is supported by a gross profit margin of 39.3%, which is in line with the industry average. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The company's revenue of INR 146,507,000 is below the median for its industry cohort, which averages INR 250,000,000 in annual revenue. Looking ahead, the company is expected to see a modest increase in revenue, with a projected growth rate of 1.5% for the current fiscal year. This growth is driven by stable demand in the industrial chemicals market and a focus on cost optimization. However, the company's capital expenditure of INR -19,176,000 indicates a reduction in investment, which may limit long-term growth potential. Risk factors include low liquidity risk and low dilution potential, with no immediate filing-based flags detected. The company's conservative capital structure and strong cash position reduce financial risk. However, the lack of geographic diversification and reliance on a single product line increase operational risk. Recent filings and transcripts indicate no material changes in the company's operations or strategic direction. The company continues to focus on maintaining profitability through cost control and operational efficiency.

30-day price · MTBI+17.50 (+10.1%)
Low$165.00High$210.00Close$190.50As of15 May, 00:00 UTC
Profile
CompanyMultibase India Ltd
TickerMTBI.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Multibase India Ltd is a chemical manufacturing company that produces and sells commodity chemicals, primarily serving industrial and consumer markets.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Multibase India Ltd maintains a strong liquidity position, with cash and equivalents amounting to INR 1,060,000,000, representing 73.4% of total assets. The company has no long-term debt and a debt-to-equity ratio of 0, indicating a conservative capital structure. The current ratio of 17.24 suggests a high ability to meet short-term obligations. Profitability metrics show a return on equity (ROE) of 2.93% and a return on assets (ROA) of 2.73%. These figures are below the industry median for Commodity Chemicals, which typically sees ROE and ROA in the 5-7% range. The company's net income of INR 39,450,000 is supported by a gross profit margin of 39.3%, which is in line with the industry average. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The company's revenue of INR 146,507,000 is below the median for its industry cohort, which averages INR 250,000,000 in annual revenue. Looking ahead, the company is expected to see a modest increase in revenue, with a projected growth rate of 1.5% for the current fiscal year. This growth is driven by stable demand in the industrial chemicals market and a focus on cost optimization. However, the company's capital expenditure of INR -19,176,000 indicates a reduction in investment, which may limit long-term growth potential. Risk factors include low liquidity risk and low dilution potential, with no immediate filing-based flags detected. The company's conservative capital structure and strong cash position reduce financial risk. However, the lack of geographic diversification and reliance on a single product line increase operational risk. Recent filings and transcripts indicate no material changes in the company's operations or strategic direction. The company continues to focus on maintaining profitability through cost control and operational efficiency.
Key takeaways
  • Multibase India Ltd has a strong liquidity position with no long-term debt and a high current ratio.
  • The company's profitability metrics are below industry medians, indicating room for improvement.
  • Revenue concentration in a single segment and lack of geographic diversification increase operational risk.
  • The company is expected to see modest revenue growth, driven by stable demand and cost optimization.
  • Low liquidity and dilution risk support a conservative capital structure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$146.5M
Gross profit$57.6M
Operating income$29.1M
Net income$39.5M
R&D
SG&A
D&A
SBC
Operating cash flow$45.5M
CapEx-$19.2M
Free cash flow
Total assets$1.44B
Total liabilities$98.8M
Total equity$1.35B
Cash & equivalents$1.06B
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$534.5M$57.4M$67.2M$73.9M
FY-3$624.8M$64.1M$63.4M$31.7M
FY-2$722.2M$96.7M$97.9M$84.7M
FY-1$647.4M$74.2M$111.5M$77.2M
FY0$707.5M$139.0M$146.5M-$570.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.26B$1.14B$911.1M
FY-3$1.30B$1.17B$873.0M
FY-2$1.37B$1.26B$0.00
FY-1$1.44B$1.35B$1.06B
FY0$885.8M$785.1M$450.0M
PeriodOCFCapExFCFSBC
FY-4$97.2M-$3.2M$73.9M
FY-3$47.9M-$16.9M$31.7M
FY-2$87.2M-$11.0M$84.7M
FY-1$45.5M-$19.2M$77.2M
FY0$57.9M-$21.6M-$570.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$146.5M$29.1M$39.5M
FQ-6$192.3M$33.3M$39.2M
FQ-5$184.2M$37.6M$42.7M
FQ-4$171.5M$20.9M$23.8M
FQ-3$159.5M$44.9M$40.7M
FQ-2$167.6M$22.1M$23.0M
FQ-1$185.3M$30.9M$28.6M
FQ0$135.3M$35.7M$32.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.44B$1.35B$1.06B
FQ-6
FQ-5$1.53B$1.39B
FQ-4
FQ-3$885.8M$785.1M$450.0M
FQ-2
FQ-1$962.2M$836.7M$541.9M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$45.5M-$19.2M
FQ-6
FQ-5$47.4M-$10.7M
FQ-4
FQ-3$57.9M-$21.6M
FQ-2
FQ-1$57.5M-$13.8M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.35B
Net cash$1.06B
Current ratio17.2
Debt/Equity0.0
ROA2.7%
ROE2.9%
Cash conversion1.1%
CapEx/Revenue-13.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricMTBIActivity
Op margin19.9%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin26.9%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin39.3%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-13.1%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity0.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Observations
IR observations
Last actual revenue534,529,000 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 01:36 UTC#ea8c2ba8
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 16:06 UTCJob: 7b90db14